A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/24/2002	WO2002026958A3 Human neprilysin protease
10/24/2002	WO2002026258A3 Treatment of immune-mediated diseases by oral administration of plasma fractions
10/24/2002	WO2002024729A3 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
10/24/2002	WO2002022777A3 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
10/24/2002	WO2002006462A3 Methylated nucleotide regulation of upa gene expression
10/24/2002	WO2002004521A3 Proteins with integrin-like activity
10/24/2002	WO2002003972A3 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
10/24/2002	WO2002002630A3 Hcn polypeptides and polynucleotides and their use in therapy
10/24/2002	WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
10/24/2002	WO2002000210A3 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
10/24/2002	WO2001096399A3 Novel interferon-induced tetraspan protein and nucleic acids encoding same
10/24/2002	WO2001085206A3 Immunosuppressive compositions comprising an immunophilin-binding compound and a gingkolide compound
10/24/2002	WO2001074848A3 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/24/2002	WO2001068676A3 Lhrh-antagonists, production and use thereof as medicament
10/24/2002	WO2001068135A9 Compositions and methods for affecting osteogenesis
10/24/2002	WO2001062797A3 G protein-coupled receptors
10/24/2002	WO2001061005A3 Molecules of the pyrin domain protein family and uses thereof
10/24/2002	WO2001059114A9 Tumor suppressor gene, p47ing3
10/24/2002	WO2001059103A9 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
10/24/2002	WO2001058526A9 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
10/24/2002	WO2001057189A9 Fas pathway genes
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001008720A9 Hypocretin and hypocretin receptors in regulation of sleep and related disorders
10/24/2002	WO1999050288A3 Mammalian blood loss-induced gene, kd312
10/24/2002	US20020157125 Growth differentiation factor-8
10/24/2002	US20020157123 Compositions and methods for treating enzyme deficiency
10/24/2002	US20020156498 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same
10/24/2002	US20020156273 Streptogramin derivatives, their preparation and compositions which contain them
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156265 DNA encoding a GABABR2 polypeptide and uses thereof
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156260 Gene encoding a polypeptide having pre-B cell growth-supporting ability
10/24/2002	US20020156259 Human adenosine deaminase
10/24/2002	US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
10/24/2002	US20020156256 Nucleic acid and amino acid sequences of a novel H-rev107-like protein for use in diagnosis, prevention, and treatment of cancer and autoimmune disorders
10/24/2002	US20020156254 Nucleotide sequences coding polypeptide for use in the treatment of stress, diabetes, cancer, inflammatory and cardiovascular disorders
10/24/2002	US20020156252 Novel Stra6 polypeptides
10/24/2002	US20020156251 Fusion protein for use in the treatment and prevention of viral diseases
10/24/2002	US20020156249 Endoderm, cardiac and neural inducing factors-oligonucleotides for expressing murine frazzled (Frzb-1) protein
10/24/2002	US20020156246 15625 receptor, a novel G-protein coupled receptor
10/24/2002	US20020156243 Adipocyte-specific protein homologs
10/24/2002	US20020156242 Cell surface molecule mediating cell adhesion and signal transmission
10/24/2002	US20020156239 Tryrosine kinases receptor protein for use in the prevention and treatment of of nervous system, inflammatory and tumor defects
10/24/2002	US20020156238 Polypeptide for use in the prevention, detection and treatment of cancer, immunological, autoimmune, inflammatory, cardiovascular, metabolic and nervous system disorders
10/24/2002	US20020156236 Peptide for use in the treatment of cell proliferative disorders
10/24/2002	US20020156235 Generating preferential oligomers; generate oligomer, deprotect, expose to phosphorous, oxidize, expose to sulfur, cleave, recover product
10/24/2002	US20020156234 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors
10/24/2002	US20020156129 Method of treating pruritus and a pharmaceutical composition for the method
10/24/2002	US20020156125 Coadministering an oral cyclosporin enhancing agent with paclitaxel or docetaxel
10/24/2002	US20020156123 Novel pharmaceutical compositions for modulating angiogenesis
10/24/2002	US20020156094 Sulfonamide interleukin-1beta converting enzyme inhibitors
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156047 Multi-arm block copolymers as drug delivery vehicles
10/24/2002	US20020156044 Use of EXT genes for the treatment of cancer and other diseases
10/24/2002	US20020156040 Antisense oligonucleotides that bind to the enzyme's start codon; inhibiting enzymes such as superoxide dismutase
10/24/2002	US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier
10/24/2002	US20020156035 NET-4 is a member of the tetraspan transmembrane receptor family; antisense molecules, ribozymes, antibodies and antibody fragments for reductin NET-4 gene expression or activity; antitumor agents
10/24/2002	US20020156034 Chemokine receptor antagonists, including peptide antagonists of CXC chemokine receptor 4 (CXCR4) for use in the treatment of hematopoietic (stem/progenitor) cells; mobilize the these cells from marrow to peripheral blood; gene therapy
10/24/2002	US20020156033 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
10/24/2002	US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide
10/24/2002	US20020156019 Method of optimizing growth hormone replacement
10/24/2002	US20020156017 Antimicrobial peptides and methods of use thereof
10/24/2002	US20020156016 Control of cell growth by altering cell membrane potentials
10/24/2002	US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/24/2002	US20020156012 Polypeptide containing the JAB subunit or the JAM domain has peptidase activity, e.g., isopeptidase activity.
10/24/2002	US20020156011 One or more colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, may comprise an antigen presenting cell that expresses a colon tumor protein
10/24/2002	US20020156010 Method of treating obesity in adult patients exhibiting primary insulin hypersecretion
10/24/2002	US20020156009 Novel interleukin - 1 Hy2 materials and methods
10/24/2002	US20020156008 Agents for blocking T cell mediated immune reactions
10/24/2002	US20020156007 Apolipoprotein analogues
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156005 m32404, a novel human trypsin and uses thereof
10/24/2002	US20020156004 Polypeptides having significant homology to the prolactin receptor protein
10/24/2002	US20020156003 Identifying a compound that modulates angiogenesis by contacting with a ILKAP polypeptide that is encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid that encodes the polypeptide
10/24/2002	US20020156002 32620, a novel human sodium-sugar symporter family member and uses thereof
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020156000 Inhibiting NF-kappa B-dependent target gene expression in a cell.
10/24/2002	US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002	US20020155996 Recombinant alpha-fetoprotein for treating cancers
10/24/2002	US20020155995 Haptoglobin-haemoglobin complex or a part thereof or a mimic thereof being operably linked to a substance; capable of binding a CD163 receptor and/or a CD163 receptor variant.
10/24/2002	US20020155994 Aggregates of human insulin derivatives
10/24/2002	US20020155991 Polyamino acid derivtive is applied to skin to improve the "camouflaging" and/or fading out of the wrinkles and/or fine lines already formed
10/24/2002	US20020155990 Method of optimizing growth hormone replacement
10/24/2002	US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002	US20020155608 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
10/24/2002	US20020155604 Compositions and methods for regulating lymphocyte activation
10/24/2002	US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002	US20020155579 Membrane derived caspase-3, compositions comprising the same and methods of use therefor
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002	US20020155570 Nucleotide sequences coding polypeptide for use in the prevention, treatment of cancer
10/24/2002	US20020155565 FAP-activated anti-tumor compounds
10/24/2002	US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002	US20020155553 Human vesicle binding protein
10/24/2002	US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases
10/24/2002	US20020155545 Chemokines expressed in pancreas
10/24/2002	US20020155544 Treatment of diabetes with synthetic beta cells
10/24/2002	US20020155542 Inhibitors for suppressing the activity of proteins displaying CIITA activity, methods for their identification and pharmaceutical compositions
10/24/2002	US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002	US20020155537 Method for making heteromultimeric polypeptides

1 ... 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 ... 3163